The Revolution of Cardiac Myosin Inhibitors in Patients With Hypertrophic Cardiomyopathy
{{output}}
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy worldwide and causes significant morbidity and mortality. For decades, medical treatment options have been limited and untargeted, with frequent need for invasive interventions not rea... ...